Sign in

CIK 0001726445

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SEER
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821153150
Phone
+1 650-453-0000
Business address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
Former names
Seer Biosciences, Inc.
  1. 4 Open-market sale PRESIDENT & CFO sold 6,797 shares at $1.97 ($13,400)
  2. 4 Open-market sale CEO AND CHAIR sold 33,838 shares at $1.97 ($66,708)
  3. 4 Grant or award Director acquired 41,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale PRESIDENT & CFO sold 6,827 shares at $2.04 ($13,955)
  6. 4 Open-market sale CEO AND CHAIR sold 33,992 shares at $2.04 ($69,483)
  7. 4 Grant or award Director acquired 17,083 shares (grant or award)
  8. 4 Grant or award Director acquired 20,500 shares (grant or award)
  9. 4 Grant or award Director acquired 20,500 shares (grant or award)
  10. 4 Grant or award Director acquired 20,500 shares (grant or award)
  11. 4 Grant or award Director acquired 20,500 shares (grant or award)
  12. 4 Planned sale Director sold 30,253 shares at $2.08 ($62,935)
  13. 4 Open-market sale PRESIDENT & CFO sold 6,760 shares at $2.08 ($14,028)
  14. 4 Open-market sale CEO AND CHAIR sold 33,663 shares at $2.08 ($69,854)
  15. 4 Shares withheld for taxes PRESIDENT & CFO gave up 26,572 shares (to pay taxes)
  16. 4 Shares withheld for taxes CEO AND CHAIR gave up 88,494 shares (to pay taxes)
  17. 4 Open-market sale PRESIDENT & CFO sold 3,550 shares at $2.24 ($7,940)
  18. 4 Open-market sale CEO AND CHAIR sold 8,068 shares at $2.24 ($18,044)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 9 · 166 filings